Direct Ethanol Biomarker Testing: PETH - Insights

Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for...

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...

New Tests Launched Archives - Page 4 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

Autoimmune Axonal Evaluation - Insights

Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' phenotypic testing approach for autoimmune axonal neuropathy. The comprehensive, serologic panel detects for antibodies with clinical relevance to the disease to provide clarity on...

Pathways Case Studies: June 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...

Hereditary movement disorders - Insights

Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.

Research Roundup Archives - Page 3 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

People Archives - Page 2 of 35 - Insights

Skip to Content MayoACCESS MayoLINK...

Industry Archives - Page 3 of 6 - Insights

Skip to Content MayoACCESS MayoLINK...

December 2023 - Coagulation and Hematopathology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Coagulation and Hematopathology.